Trial
NCT03009877
Preoxygenation With Optiflow™ in Morbidly Obese Patients is Superior to Face Mask
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Montefiore Medical Center
Collaborators
The University of Texas Health Science Center, Houston; M.D. Anderson Cancer Center
Condition
Obesity, Morbid
Intervention
Optiflow F&P 850™ System
Why stopped
withdrawn prior to IRB approval
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-27